Alcon announces launch of AcrySof IQ Vivity in India,
Equipment

Alcon announces launch of AcrySof IQ Vivity in India,

It is the first presbyopia-correcting lens implant for cataract surgery

  • By IPP Bureau | October 19, 2021

Alcon, the global leader in eye care announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology – the AcrySof  IQ Vivity IOL (Vivity). This new PC-IOL is now available to Indian ophthalmologists for their patients undergoing cataract surgery. Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.

Vivity is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE technology, which stretches and shifts light without splitting it.1-2  Vivity delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances.2-4  

Vivity expands Alcon’s growing portfolio of PC-IOLs and is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally.6 According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision.

Additionally, 94% and 92% of Vivity patients reported superior vision at distance and arm’s length, respectively, without glasses in bright light.10,11

“Traditional IOLs typically address distance vision. The new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India “Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities, post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.

 

Upcoming E-conference

Other Related stories

Startup

Digitization